孕期高血压患者的维生素D水平,D-二聚体和血小板参数水平之间的关系
Pingping Wang1, Jin Yao2, Yaqiong Li3
1Department of Medical Laboratory, Luoyang Maternal and Child Health Hospital, Luoyang, Henan, China.
Frontiers in immunology
|April 1, 2025
概括
孕期高血压与维生素D不足和血小板功能异常有关. 改善维生素D可能有助于管理这种妊娠并发症.
科学领域:
- 产科和妇科 产科和妇科
- 临床生物化学 临床生物化学
- 血液学 血液学 血液学
背景情况:
- 孕期高血压是一种严重的妊娠并发症,影响母亲和胎儿的健康.
- 新兴的研究表明,维生素D,D-二次体和血小板参数在它的发展中起着作用.
研究的目的:
- 研究怀孕期高血压妇女维生素D水平,D-二次体和血小板参数之间的关联.
主要方法:
- 对90名妊娠高血压患者和90名对照患者的临床数据的回顾性分析.
- 组间的血小板计数 (PLT),平均血小板体积 (MPV),血小板分布宽度 (PDW),D-二次数和维生素D (Vit D) 水平的比较.
主要成果:
- 与对照组相比,妊娠高血压组的维生素D和PLT显著降低,但MPV和PDW较高.
- 维生素D水平与D-二次体,MPV和PDW相关.
- 维生素D,D-二次和血小板参数被确定为妊娠高血压的显著预测因素.
结论:
- 妊娠期高血压患者表现出维生素D缺乏和血小板功能改变.
- 维生素D可以通过调节血小板活动和凝血来影响疾病的发展.
- 提高维生素D状态可能是管理妊娠高血压的潜在治疗策略.
关键词:
D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D相关性 相关性 相关性孕期高血压是什么意思血小板参数 血小板参数维生素D是维生素D的重要组成部分.更多相关视频
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
8.7K
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
441
相关概念视频
Formation of the Platelet Plug
3.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
570
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
570
Disorders of Hemostasis
664
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
664
Pathophysiology of Diabetes
822
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
822
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
